Don't wanna be here? Send us removal request.
Text
Human Granulocyte Colony-stimulating Factor Injection
Boosting your immune system is crucial for maintaining optimal health and aiding in a speedy recovery when illness strikes. While there are countless ways to support your body's natural defense mechanisms, one powerful tool that often goes unnoticed is human granulocyte colony stimulating factor (G-CSF) injections. This remarkable treatment has the potential to unlock the full potential of your immune system, giving it the boost it needs to keep you healthy and aid in faster healing. In this blog post, we will delve into the fascinating world of G-CSF therapy, exploring its role in the immune system, its benefits for health and recovery, how it works within the body's intricate mechanisms, as well as current research on its efficacy. Join us on this journey of discovery as we unveil the incredible power of G-CSF injections!
0 notes
Text
Human Erythropoietin Injection
EPOSINO is the first batch of human erythropoietin approved for R&D in China and obtained the New Drug Certificate and NMPA's official approval number. It is complete in dosage forms and strengths and firstly administrated by pre-filled syringes for more convenient clinical drug selection. As an industry-leading product, it has been accessed into and sold in more than 30 countries, including Brazil, the Philippines and Indonesia.
0 notes
Text
Combined Clostridium and Bifidobacterium,Live
Combined Clostridium Butyricum and Bifidobacterium Powder/Capsule, Live (CLOBICO) is a combination of clostridium butyricunm and bifidobacterium infantis. Both bacterial strains are dominant in autochthonous intestinal flora and can synergistically promote the growth of each other. With proven immunoregulatory effect and a wide range of clinical applications and evidence-based support, it is a probiotic that is explicitly approved for use by the old and the young, as well as pregnant women before and after delivery, in the package insert.
0 notes
Text

Bevacizumab Injection
Bevacizumab(Arketin), an anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF mAb), specifi_x005fcally binds to VEGF to prevent VEGF from binding to its receptor, thereby reducing neovascularization, inducing degeneration of existing blood vessels and inhibiting tumor growth. As a broad-spectrum anti-tumor agent, bevacizumab is a standard regimen recommended in treatment guidelines for various malig_x0002_nancies worldwide. Since entering the market, its efficacy and safety have been widely demonstrated in clinical practice.
0 notes
Text

Adalimumab Solution for Injection
Adalimumab(Ahrasin) is a fully human anti-tumor necrosis factor-α(TNF-α) monoclonal antibody, a biosimilar drug of HUMIRA. Excessive inflammation in a variety of immune-mediated diseases in humans is associated with TNF-α.
0 notes